Skip to content

Medical emergency? What to do

Pfizer ready to monitor inhaled-insulin patients

3-RXPublished September 10, 20052 min read

Key points

  • Pfizer Inc is ready to launch a patient-monitoring scheme to assess the safety of its novel inhaled-insulin drug Exubera if the product is approved for use, its worldwide head of development said on Thursday.
  • Most industry analysts expect a green light for the medicine, which has been touted as a potential $2 billion-a-year seller.
  • "This is a new departure and, of course, safety must be a major agenda item," he told Reuters in a telephone interview during a visit to Britain.
  • Exubera could revolutionise treatment for diabetics by doing away with the need for some, or all, insulin injections.

Pfizer Inc is ready to launch a patient-monitoring scheme to assess the safety of its novel inhaled-insulin drug Exubera if the product is approved for use, its worldwide head of development said on Thursday.

Exubera is being developed with Sanofi-Aventis SA and Nektar Therapeutics, and is due to be reviewed by a U.S. Food and Drug Administration (FDA) panel later on Thursday.

Most industry analysts expect a green light for the medicine, which has been touted as a potential $2 billion-a-year seller. But there are concerns about potential adverse effects on the lungs or blood sugar levels.

Pfizer's development head, Declan Doogan, said the company recognised that using Exubera raised safety issues and the company was therefore prepared for a proper follow-up programme among users.

"This is a new departure and, of course, safety must be a major agenda item," he told Reuters in a telephone interview during a visit to Britain.

"We have, I believe, a compelling approach to how we are going to evaluate patients in the post-approval world and, of course, we are going to be agreeing that with the regulatory authorities ... I don't think you will find us resistant."

Exubera could revolutionise treatment for diabetics by doing away with the need for some, or all, insulin injections.

However, the FDA said in documents released on Wednesday said that the risks involved with using the product needed to be scrutinised closely.

Doogan declined to comment on widespread speculation that Pfizer, the world's biggest drug maker, was looking to buy its partner Sanofi out of the project, but he confirmed there were talks between the two companies about its future.

"We are in discussions with Sanofi about how the compound will get managed into the future," he said.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Experimental drug shrinks cancer tumors

An experimental cancer drug successfully shrank tumors in patients with different kinds of cancer, including typically hard-to-treat lung cancers, according to a new study. Oncologists said the research was…

4 min read

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.